Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting TRIM24 promotes neuroblastoma differentiation and decreases tumorigenicity via LSD1/CoREST complex

Published:2023-07-19 Issue: Volume: Page:
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Shi Qiqi,Yu Bo,Zhang Yingwen,Yang Yi,Xu Chenxin,Zhang Mingda,Chen Guoyu,Luo Fei,Sun Bowen,Yang Ru,Li Yanxin,Feng Haizhong

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13402-023-00843-4.pdf

Reference39 articles.

1. S.L. Cohn, A.D. Pearson, W.B. London, T. Monclair, P.F. Ambros, G.M. Brodeur, A. Faldum, B. Hero, T. Iehara, D. Machin, V. Mosseri, T. Simon, A. Garaventa, V. Castel, K.K. Matthay, I.T. Force, The international neuroblastoma risk group (INRG) classification system: An INRG task Force report. J Clin Oncol 27, 289–297 (2009)

2. J.M. Maris, Recent advances in neuroblastoma. N Engl J Med 362, 2202–2211 (2010)

3. C.P. Reynolds, K.K. Matthay, J.G. Villablanca, B.J. Maurer, Retinoid therapy of high-risk neuroblastoma. Cancer Lett 197, 185–192 (2003)

4. K.K. Matthay, C.P. Reynolds, R.C. Seeger, H. Shimada, E.S. Adkins, D. Haas-Kogan, R.B. Gerbing, W.B. London, J.G. Villablanca, Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: A children's oncology group study. J Clin Oncol 27, 1007–1013 (2009)

5. S. Hatakeyama, TRIM proteins and cancer. Nat Rev Cancer 11, 792–804 (2011)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The tripartite motif-containing 24 is a multifunctional player in human cancer;Cell & Bioscience;2024-08-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3